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Introduction Aims
Materials and Methods 
The association between microbiota composition and 
obesity 
Obesity and its associated disorders are one of the major health problems 
in the developed world. Obesity has been mainly related with an energy 
imbalance when energy intake exceeds energy expenditure, however 
other factors must also be considered.
Recent insight suggests that an altered composition and diversity of gut
microbiota could play a critical role in energy balance and metabolism,
implicating it as a major factor in the development of obesity [1].
Targeting microbiota in order to modulate the microbiota composition
with probiotics is considered as a promising strategy for the development
of new solutions for its treatment [2].
The objectives of this project are:
 To understand the symbiotic relationship between the intestinal flora and the human
organism underlying the microbiota functions.
 To determine the mechanism of the intestinal microbiota in the development of
obesity.
 To determine the effectiveness of the action of probiotics as a possible therapeutic
strategy.
 The functions of the microbiota can
be broadly categorized into three
groups: metabolic , protective and
structural.
Dysbiosis microbiota
Literatures research on Pubmed and Google Scholar database using terms such as
“obesity”, “probiotics” , “gut microbiota” or a combination of them. Selected papers,
including reviews, were published between 2005 and 2016 and chosen on the basis of
their content.
Metabolic
• Fermentation of non-
digestible substrates 
• Production of vitamins , 
amino acids  biosynthesis 
and xenobiotic 
metabolism
• Production of SCFAs 
(Acetate, propionate and 
butyrate)
Structural
• Epithelial cell 
growth and 
differentiation 
regulation
• Intestinal villi and 
crypts development
• Mucus layer 
properties and tight 
junctional 
permeability
Protective
• Colonization 
resistance
• Innate and adaptive 
immunity
• Inflammatory 
cytokine regulation
Bacterial
Phylotypes 
Feeding
Individual genetic 
background
• Obesity has been correlated with the
altered ratio of the two dominant
phylum groups (>90%) Firmicutes
Bacteroidetes
Treatment approach 
 The host’s intrinsic 
characteristics, such as genetic 
factors, the state of the immune 
system and nutrition influence 
the composition and metabolic 
activity of the gut microbiota. 
Loss of diversity and 
altered composition 
has a negative 
impact on health 
 The human gut is home to 𝟏𝟎𝟏𝟒 bacteria, located mainly in the colon.
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• Suggested mechanisms that link the changes observed in gut microbiota composition 
with the obesity and associated disorders : 
Fig.3: Role of probiotics in lowering gut
permeability, serum lipopolysaccharide
and inflammatory status.
Probiotics mechanisms of actions:
Conclusions 
 There is clear evidence that the gut microbiome has a profound effect
on the balance between health and disease.
 Obesity is associated with the abundance of Firmicutes and a decrease
of Bacteroidetes. These alterations are linked with adiposity,
inflammation and energy homeostasis of the individual.
 Evidence suggests that probiotics offer a promise for the treatment of
obesity. They have shown efficacy reducing fat accumulation through
their effects on controlling food intake, body weight and gut
microbiota.
 In order to improve intervention strategies to manage obesity and
obesity-related diseases, further studies are required. It is needed to
better understanding of the interactions between the host and the gut
microbes in individuals with obesity.
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Fig. 2: Role of the intestinal microbiota in fat-induced changes that contributes to obesity development. 
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Fig.1: The human gut microbiota has many positive benefits within the human body,
which include maintaining immune, energy, and metabolic homeostasis.
Lactobacillus and Bifidobacterium are
the probiotic strains typically consumed
by humans.
Lactobacillus gasseri
appears to be the
probiotic strain that can
best assist weight loss in
humans.
PROBIOTICS
Live microorganisms that when
administrated in adequate
amounts have been shown to
confer health benefits to the host.
